openPR Logo
Press release

Regenerative Medicine Market Outlook, Size, Share, Growth Prospects and Emerging Opportunities 2022-2027

03-14-2023 08:19 AM CET | Health & Medicine

Press release from: IMARC Group

Regenerative Medicine Market

Regenerative Medicine Market

According to the latest report by IMARC Group, titled "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on regenerative medicine market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 50.44 Billion by 2027, exhibiting at a CAGR of 22.6% during 2022-2027.

Regenerative medicine is a branch of biomedical science that involves replacing or restoring damaged tissues, organs, and cells. It also includes the utilization of laboratory-developed stem cells to implant into the body for regenerating damaged bones, blood vessels, cartilage, and organs that are impaired due to age, diseases and trauma. It deals with the repairing of injured joints and tissue that help in reducing inflammation and preventing scar tissue formation. Consequently, it is adopted in various clinical therapeutic procedures, including cell immunomodulation and tissue engineering therapies, and is extensively adopted for the treatment of numerous chronic diseases, such as Alzheimer's, Parkinson's, cardiovascular disorders (CVDs), cancer, osteoporosis, and spinal cord injuries.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/regenerative-medicine-market/requestsample

Market Trends:

The increasing prevalence of chronic disorders among the masses is driving the global market. Moreover, the growing demand for organ transplantation among patients and the commercialization of regenerative medicines are providing a thrust to the market. Furthermore, continual technological advancements in cell-based therapies, including the adoption of artificial intelligence (AI) in the production of regenerative medicines and the development of 3D bioprinting techniques, are acting as growth-inducing factors. In line with this, numerous leading players are focussing on extensive research and development (R&D) activities to develop new technologies that offer better results in newly generated cells creating a positive market outlook. Other factors, including increasing government support and emerging healthcare infrastructure, are also influencing the market.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/regenerative-medicine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Allergan PLC (AbbVie Inc.)
• Amgen Inc.
• Baxter International Inc.
• BD (Becton, Dickinson and Company)
• Integra Lifesciences Holdings Corporation
• Medtronic plc
• Mimedx Group Inc.
• Novartis AG
• Osiris Therapeutics Inc. (Smith & Nephew plc)
• Thermo Fisher Scientific Inc

Regenerative Medicine Market Segmentation:

Our report has categorized the market based on region, type, application and end user.

Breakup by Type:
• Stem Cell Therapy
• Biomaterial
• Tissue Engineering
• Others

Breakup by Application:
• Bone Graft Substitutes
• Osteoarticular Diseases
• Dermatology
• Cardiovascular
• Central Nervous System
• Others

Breakup by End User:
• Hospitals
• Specialty Clinics
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Browse Other Reports:

https://www.einpresswire.com/article/619661246/speech-analytics-market-segmentation-challenges-industry-insight-growth-drivers-and-opportunities-2022-2027

https://www.einpresswire.com/article/619675484/robotics-market-overview-growth-prospects-future-outlook-development-factors-and-forecast-2023-2028

https://www.einpresswire.com/article/619836786/toys-market-size-is-projected-to-surpass-us-267-9-billion-by-2028-growth-rate-cagr-of-7-2

https://www.einpresswire.com/article/619842766/chocolate-market-is-anticipated-to-reach-around-us-181-8-billion-by-2028-growth-rate-of-2-4

https://www.einpresswire.com/article/621836517/real-estate-market-outlook-growth-prospects-future-projections-and-emerging-opportunities-2023-2028

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Medicine Market Outlook, Size, Share, Growth Prospects and Emerging Opportunities 2022-2027 here

News-ID: 2973632 • Views: 163

More Releases from IMARC Group

Container and Kubernetes Security Market Size Going To Hit US$ 4,469 Million by …
According to IMARC Group's latest report, titled "𝐂𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐫 𝐚𝐧𝐝 𝐊𝐮𝐛𝐞𝐫𝐧𝐞𝐭𝐞𝐬 𝐒𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 2023-2028", the container and kubernetes security market reached US$ 1,080 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 4,469 Million by 2028, exhibiting a CAGR of 24.6% during 2023-2028. Container and Kubernetes security represent open-source systems for automating the deployment, management, and scaling of containerized
Carbon Management Software Market to Reach US$ 26.99 Billion by 2028
According to IMARC Group's latest research report, titled "Carbon Management Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global carbon management software market size reached US$ 13.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 26.99 Billion by 2028, exhibiting a growth rate (CAGR) of 12.02% during 2023-2028. Get Free Sample Copy of Report at - https://www.imarcgroup.com/carbon-management-software-market/requestsample Carbon Management Software Market Outlook: Carbon
US$ 260.5 Billion, Aquafeed Market Size Rise at +8.9% CAGR by 2028
IMARC Group's latest report, titled "Aquafeed Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," finds that the global aquafeed market size reached US$ 155.3 Billion in 2022. Looking forward, IMARC Group expects the market value to reach US$ 260.5 Billion by 2028, growing at a CAGR of 8.9% during the forecast period (2023-2028). Request Free Sample Report: https://www.imarcgroup.com/aquafeed-market/requestsample Aquafeed refers to any feed manufactured commercially for aquatic farmed
Colposcopes Market To Reach US$ 841.2 Million by 2028 | Growth Rate (CAGR) of 6. …
According to the latest report by IMARC Group, titled "Colposcopes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global colposcopes market size reached US$ 594.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 841.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028. Colposcopes are medical devices used by gynecologists to closely examine the cervix, and vagina, of

All 5 Releases


More Releases for Regenerative

Emerging Trends in Regenerative Medicine Market
Advances in tissue-engineering therapy to impact the regenerative medicine market growth. The global regenerative medicine market was valued at USD 4.67 billion in 2020 and is projected to reach 27.08 billion in 2026 growing at a CAGR of 30.14% according to a report by Arizton. The global regenerative medicine market's positive trend and growth are attributed to the high prevalence and incidence rates of diseases such as cancers and genetic disorders
Tissue Regenerative Therapy Market 2021 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Tissue Regenerative Therapy industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Tissue Regenerative Therapy market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Tissue Regenerative Therapy report includes a
Regenerative Medicine Market Perceptible over 2025
Regenerative Medicine Market: Snapshot Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes. Doing this may involve a partial or complete reengineering of human cells so that they start to function normally. Regenerative medicine also involves the attempts to grow tissues and organs in a
Regenerative Medicine Landscape
Boston, MA ReportsWorldwide has announced the addition of a new report title Regenerative Medicine Landscape to its growing collection of premium market research reports. The competitive landscape for regenerative medicine continues to evolve. As private sector investment in active players continues, efforts by governments in the US and EU are helping to advance the field, including the recent passage of the 21st Century Cures Act in the US, providing a special status
Regenerative Medicines Sales Report 2017
"Global Regenerative Medicines Sales Market Report 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Regenerative Medicine Market: Transformative Effect of Regenerative Medicine on …
Regenerative medicine, according to the US National Institutes of Health (NIH), is the process of developing functional tissues for the repair and/or replacement of damaged organs or tissues. Having lost function due to disease, congenital defects, and age, these tissues or organs are regenerated to establish and restore normal function. Regenerative medicine is used in a wide range of applications including neurology, musculoskeletal, cardiovascular, and orthopedic. Earlier this month, a